Details of the Drug Formulations

General Information of Drug (ID: DMO50U2)

Drug Name
Naratriptan Drug Info
Synonyms
Colatan; Naramig; Naratriptanum; Amerge (TN); Naramig (TN); Naratriptan (INN); Amerge, Naramig,Naratriptan; N-methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide; N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide; N-methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide
Indication
Disease Entry ICD 11 Status REF
Headache 8A80-8A84 Approved [1]
Migraine 8A80 Approved [2]
Migraine disorder Approved [1]
Therapeutic Class
Vasoconstrictor Agents
Cross-matching ID
PubChem CID
4440
ChEBI ID
CHEBI:7478
CAS Number
121679-13-8
TTD ID
D0T3KI
VARIDT ID
DR01282
INTEDE ID
DR1131
ACDINA ID
D00457

Full List of Drug Formulations Containing This Drug

Naratriptan 2.5 mg tablet
Company Formulation ID FDA Description
Teva Pharmaceuticals F15103 Lactose monohydrate; Fd&c blue no. 1; Magnesium stearate; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Croscarmellose sodium; Polyethylene glycol 3350; Polyethylene glycol 4000; Polyvinyl alcohol; Aluminum oxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h)
Paddock Laboratories, F15101 Anhydrous lactose; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Magnesium stearate; Titanium dioxide; Triacetin; Croscarmellose sodium; Aluminum oxide; Cellulose, microcrystalline; Hypromelloses
GlaxoSmithKline F15104 Lactose, unspecified form; Fd&c blue no. 2; Indigotindisulfonate sodium; Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Triacetin; Croscarmellose sodium; Hypromellose, unspecified; Microcrystalline cellulose
Sandoz F15100 Anhydrous lactose; Lactose monohydrate; Fd&c blue no. 2; Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Triacetin; Croscarmellose sodium; Cellulose, microcrystalline; Hypromellose 2910 (15 mpa.s)
Mylan Pharamceuticals F15097 Anhydrous lactose; Fd&c blue no. 2; Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Triacetin; Croscarmellose sodium; Cellulose, microcrystalline; Hypromelloses
OrchidPharma F15102 Anhydrous lactose; Fd&c blue no. 2; Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Triacetin; Croscarmellose sodium; Cellulose, microcrystalline; Hypromellose 2910 (6 mpa.s)
West-Ward Pharmaceticals F15098 Anhydrous lactose; Magnesium stearate; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline
Heritage Pharmaceuticals F15099 Anhydrous lactose; Magnesium stearate; Talc; Titanium dioxide; Croscarmellose sodium; Cellulose, microcrystalline; Hypromellose 2910 (6 mpa.s); Polyethylene glycol 8000
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Formulation(s)
Naratriptan 1 mg tablet
Company Formulation ID FDA Description
Teva Pharmaceuticals F15095 Lactose monohydrate; Fd&c blue no. 1; Magnesium stearate; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Croscarmellose sodium; Polyethylene glycol 4000; Polyvinyl alcohol; Aluminum oxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Polyethylene glycol 3500
Mylan Pharamceuticals F15089 Anhydrous lactose; Fd&c blue no. 2; Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Triacetin; Croscarmellose sodium; Cellulose, microcrystalline; Hypromelloses
Heritage Pharmaceuticals F15091 Anhydrous lactose; Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Croscarmellose sodium; Polyethylene glycol 400; Cellulose, microcrystalline; Hypromellose 2910 (5 mpa.s)
West-Ward Pharmaceticals F15090 Anhydrous lactose; Magnesium stearate; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline
Sandoz F15092 Anhydrous lactose; Lactose monohydrate; Magnesium stearate; Titanium dioxide; Triacetin; Croscarmellose sodium; Cellulose, microcrystalline; Hypromellose 2910 (15 mpa.s)
Paddock Laboratories, F15093 Anhydrous lactose; Magnesium stearate; Titanium dioxide; Triacetin; Croscarmellose sodium; Cellulose, microcrystalline; Hypromelloses
OrchidPharma F15094 Anhydrous lactose; Magnesium stearate; Titanium dioxide; Triacetin; Croscarmellose sodium; Cellulose, microcrystalline; Hypromellose 2910 (6 mpa.s)
GlaxoSmithKline F15096 Lactose, unspecified form; Magnesium stearate; Titanium dioxide; Triacetin; Croscarmellose sodium; Hypromellose, unspecified; Microcrystalline cellulose
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Formulation(s)

References

1 Naratriptan FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 45).